652 related articles for article (PubMed ID: 30559744)
1. B Cell Siglecs-News on Signaling and Its Interplay With Ligand Binding.
Meyer SJ; Linder AT; Brandl C; Nitschke L
Front Immunol; 2018; 9():2820. PubMed ID: 30559744
[TBL] [Abstract][Full Text] [Related]
2. CD22 and Siglec-G regulate inhibition of B-cell signaling by sialic acid ligand binding and control B-cell tolerance.
Nitschke L
Glycobiology; 2014 Sep; 24(9):807-17. PubMed ID: 25002414
[TBL] [Abstract][Full Text] [Related]
3. Murine Red Blood Cells Lack Ligands for B Cell Siglecs, Allowing Strong Activation by Erythrocyte Surface Antigens.
Spiller F; Nycholat CM; Kikuchi C; Paulson JC; Macauley MS
J Immunol; 2018 Feb; 200(3):949-956. PubMed ID: 29288201
[TBL] [Abstract][Full Text] [Related]
4. Sialic Acid Ligand Binding of CD22 and Siglec-G Determines Distinct B Cell Functions but Is Dispensable for B Cell Tolerance Induction.
Özgör L; Meyer SJ; Korn M; Terörde K; Nitschke L
J Immunol; 2018 Oct; 201(7):2107-2116. PubMed ID: 30143587
[TBL] [Abstract][Full Text] [Related]
5. The ligand interactions of B cell Siglecs are involved in the prevention of autoimmunity to sialylated self-antigens and in the quality control of signaling-competent B cells.
Tsubata T
Int Immunol; 2023 Oct; 35(10):461-473. PubMed ID: 37504378
[TBL] [Abstract][Full Text] [Related]
6. CD22-Binding Synthetic Sialosides Regulate B Lymphocyte Proliferation Through CD22 Ligand-Dependent and Independent Pathways, and Enhance Antibody Production in Mice.
Matsubara N; Imamura A; Yonemizu T; Akatsu C; Yang H; Ueki A; Watanabe N; Abdu-Allah H; Numoto N; Takematsu H; Kitazume S; Tedder TF; Marth JD; Ito N; Ando H; Ishida H; Kiso M; Tsubata T
Front Immunol; 2018; 9():820. PubMed ID: 29725338
[TBL] [Abstract][Full Text] [Related]
7. Ligand Recognition Determines the Role of Inhibitory B Cell Co-receptors in the Regulation of B Cell Homeostasis and Autoimmunity.
Tsubata T
Front Immunol; 2018; 9():2276. PubMed ID: 30333834
[TBL] [Abstract][Full Text] [Related]
8. CD22 Controls Germinal Center B Cell Receptor Signaling, Which Influences Plasma Cell and Memory B Cell Output.
Meyer SJ; Steffensen M; Acs A; Weisenburger T; Wadewitz C; Winkler TH; Nitschke L
J Immunol; 2021 Aug; 207(4):1018-1032. PubMed ID: 34330755
[TBL] [Abstract][Full Text] [Related]
9. CD22 and Siglec-G: B-cell inhibitory receptors with distinct functions.
Nitschke L
Immunol Rev; 2009 Jul; 230(1):128-43. PubMed ID: 19594633
[TBL] [Abstract][Full Text] [Related]
10. Identification of Siglec Ligands Using a Proximity Labeling Method.
Chang L; Chen YJ; Fan CY; Tang CJ; Chen YH; Low PY; Ventura A; Lin CC; Chen YJ; Angata T
J Proteome Res; 2017 Oct; 16(10):3929-3941. PubMed ID: 28899088
[TBL] [Abstract][Full Text] [Related]
11. Decoration of T-independent antigen with ligands for CD22 and Siglec-G can suppress immunity and induce B cell tolerance in vivo.
Duong BH; Tian H; Ota T; Completo G; Han S; Vela JL; Ota M; Kubitz M; Bovin N; Paulson JC; Nemazee D
J Exp Med; 2010 Jan; 207(1):173-87. PubMed ID: 20038598
[TBL] [Abstract][Full Text] [Related]
12. The role of CD22 and Siglec-G in B-cell tolerance and autoimmune disease.
Müller J; Nitschke L
Nat Rev Rheumatol; 2014 Jul; 10(7):422-8. PubMed ID: 24763061
[TBL] [Abstract][Full Text] [Related]
13. Regulation of B cell development and B cell signalling by CD22 and its ligands alpha2,6-linked sialic acids.
Ghosh S; Bandulet C; Nitschke L
Int Immunol; 2006 Apr; 18(4):603-11. PubMed ID: 16497829
[TBL] [Abstract][Full Text] [Related]
14. Sialic acids and autoimmune disease.
Mahajan VS; Pillai S
Immunol Rev; 2016 Jan; 269(1):145-61. PubMed ID: 26683151
[TBL] [Abstract][Full Text] [Related]
15. Coordinated roles for glycans in regulating the inhibitory function of CD22 on B cells.
Enterina JR; Jung J; Macauley MS
Biomed J; 2019 Aug; 42(4):218-232. PubMed ID: 31627864
[TBL] [Abstract][Full Text] [Related]
16. Regulation of B cell functions by the sialic acid-binding receptors siglec-G and CD22.
Jellusova J; Nitschke L
Front Immunol; 2011; 2():96. PubMed ID: 22566885
[TBL] [Abstract][Full Text] [Related]
17. CD22: A Regulator of Innate and Adaptive B Cell Responses and Autoimmunity.
Clark EA; Giltiay NV
Front Immunol; 2018; 9():2235. PubMed ID: 30323814
[TBL] [Abstract][Full Text] [Related]
18. Copresentation of antigen and ligands of Siglec-G induces B cell tolerance independent of CD22.
Pfrengle F; Macauley MS; Kawasaki N; Paulson JC
J Immunol; 2013 Aug; 191(4):1724-31. PubMed ID: 23836061
[TBL] [Abstract][Full Text] [Related]
19. CD22 x Siglec-G double-deficient mice have massively increased B1 cell numbers and develop systemic autoimmunity.
Jellusova J; Wellmann U; Amann K; Winkler TH; Nitschke L
J Immunol; 2010 Apr; 184(7):3618-27. PubMed ID: 20200274
[TBL] [Abstract][Full Text] [Related]
20. The Protein Tyrosine Phosphatase SHP-1 (PTPN6) but Not CD45 (PTPRC) Is Essential for the Ligand-Mediated Regulation of CD22 in BCR-Ligated B Cells.
Alborzian Deh Sheikh A; Akatsu C; Abdu-Allah HHM; Suganuma Y; Imamura A; Ando H; Takematsu H; Ishida H; Tsubata T
J Immunol; 2021 Jun; 206(11):2544-2551. PubMed ID: 33990399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
